NovaBay Pharmaceuticals, Inc. Annual Income Tax Expense (Benefit) in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
NovaBay Pharmaceuticals, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2010 to 2022.
  • NovaBay Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $0.000.
  • NovaBay Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • NovaBay Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000, a 100% decline from 2020.
  • NovaBay Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2020 was $5K, a 16.7% decline from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $0 -$5K -100% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $5K -$1K -16.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $6K +$2K +50% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
2018 $4K +$1K +33.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-25
2017 $3K +$1K +50% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
2016 $2K $0 0% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-29
2015 $2K $0 0% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-21
2014 $2K +$400 +25% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-23
2013 $1.6K -$400 -20% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-04
2012 $2K $0 0% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
2011 $2K -$48K -96% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-06
2010 $50K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.